Avastin - bevacizumab
Navigation: NDC > Supplier starting with: G > GENENTECH, INC.| Field | Value |
|---|---|
| NDC Code: | 50242-061 |
| Proprietary Name: | Avastin |
| Suffix: | |
| Non-Proprietary Name: | bevacizumab |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 26-02-2004 |
| Category Name: | BLA |
| Application Number: | BLA125085 |
| Labeler: | GENENTECH, INC. |
| Substance Name: | BEVACIZUMAB |
| Active Numerator Strength: | 400 |
| Active Ingredient Unit: | mg/16mL |
| Pharm Classes: | Vascular Endothelial Growth Factor Receptor Inhibitors [MoA],Vascular Endothelial Growth Factor-directed Antibody [EPC],Vascular Endothelial Growth Factor-directed Antibody Interactions [MoA] |
| DEA Schedule: |